Lincare Holdings Beats on Revenue, Matches Expectations on EPS

Updated

Lincare Holdings (NAS: LNCR) reported earnings Feb. 6. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Lincare Holdings beat expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded and GAAP earnings per share expanded.

Margins contracted across the board.

Revenue details
Lincare Holdings booked revenue of $474.8 million. The eight analysts polled by S&P Capital IQ hoped for revenue of $455.1 million. Sales were 17% higher than the prior-year quarter's $418.7 million.

anImage
anImage

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $0.48. The 10 earnings estimates compiled by S&P Capital IQ averaged $0.48 per share on the same basis. GAAP EPS of $0.51 for Q3 were 6.3% higher than the prior-year quarter's $0.48 per share.

anImage
anImage

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 44.4%, 1,950 basis points worse than the prior-year quarter. Operating margin was 16.9%, 310 basis points worse than the prior-year quarter. Net margin was 9.1%, 180 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $483.8 million. On the bottom line, the average EPS estimate is $0.51.

Next year's average estimate for revenue is $1.84 billion. The average EPS estimate is $1.93.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 127 members out of 152 rating the stock outperform, and 25 members rating it underperform. Among 69 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 62 give Lincare Holdings a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Lincare Holdings is hold, with an average price target of $27.35.

If you're interested in health care stocks like Lincare Holdings, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.

At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement